FindTrial
Sign In

Proportion of antibiotic resistant organism in infections given initial therapy with higher antibiotics

Empirical upfront use of Higher Generation Broad-spectrum Antibiotics: Clinical microbiology correlation-a cross-sectional study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/01/049058
Enrollment
777
Registered
2023-01-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: R652- Severe sepsis

Interventions

None listed

Sponsors

MOSC Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a)Patients above 18 yrs of age b)Patients administered Higher generation broad-spectrum antibiotics empirically c)Culture specimen was taken before starting primary therapy

Exclusion criteria

Exclusion criteria: a)Improper documentation of details b)Patients given higher-generation broad-spectrum antibiotics(HGBSA) without index culture specimens taken.

Design outcomes

Primary

MeasureTime frame
To estimate the proportion of patients started on higher generation broad-spectrum antibiotics who have MDR (multidrug-resistant) organisms in index microbiology culture.Timepoint: Every 4 weeks—

Secondary

MeasureTime frame
to determine the clinical parameters associated with MDR microbial infections.Timepoint: 1 year—

Countries

India

Contacts

Public ContactSantosh Balakrishnan

MOSC Medical College

santosurg@gmail.com9747058458

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026